Mylan And Teva And Copaxone, Explained
October 04, 2017 at 14:35 PM EDT
Mylan N.V. (NASDAQ: MYL) announced Tuesday that the FDA has approved its Abbreviated New Drug Application for the first generic for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.